CMPI in the Washington Times: Drugs of Choice

  • by: |
  • 03/27/2012
Next week, the FDA will be holding a hearing about letting consumers buy commonly used prescription drugs without a prescription, signaling FDA recognition that empowering consumers to make health care choices is the key to better health at a lower cost. The agency’s proposal is a refreshing departure from the usual administration’s practice of expanding government’s role in our daily lives. Yet so-called consumer groups that want the government to tell Americans how to eat, what cars to drive and what medicines to take are opposing even this small step toward medical freedom.

Indeed, the FDA proposal recognizes that individuals, armed with increasingly individualized information on what’s best for them, can make better decisions than a system where what is spent on health care is determined by bureaucrats. More consumers want more personal responsibility and freedom in making health care decisions, not less. They want to spend less time and money on medical care. So why would some groups oppose making more medications that have been widely used for years - for such conditions as high cholesterol, migraines, and hypertension - more accessible?

Groups such as the Center for Science in the Public Interest and Public Citizen claim the FDA proposal will “permit” people to use more medicines without solid information. On the contrary, the explosion of diagnostics, applications and online communities has increased our ability to responsibly take control of our health and well-being. In today’s digital world, we can use our smartphones to obtain test results and access information tailored to our diagnosis, genetics, health goals and lifestyle. Making drugs for osteoporosis prevention, birth control, migraines, cholesterol and erectile dysfunction available without a prescription would, with appropriate safeguards and new health-information tools, empower people to look after themselves. In fact, evidence shows that moving prescription drugs over the counter (OTC) helps people stay on track with their treatment regimen.

Critics often point to what they claim is misuse of cough medicines as an argument for more FDA regulation of OTC products, not less. But a recent survey I conducted on how American families treat coughs and colds underscores the opportunity self-care can offer to improve health. Over the past year, 61 million consumers avoided missing work, school or other scheduled appointments due to illness because they had access to OTC cough medicines to alleviate their symptoms. And nearly 75 percent of all consumers surveyed complemented cough and cold medicine use with rest, fluids (including chicken soup) and other “home” remedies.

The nearly a third of patients who see a physician for a cold wind up spending $7 billion on office visits and another $2 billion on antibiotics a year even though antibiotics don’t work for such ailments. If we were all forced to run to the doctor and get a prescription every time we coughed or were stuffed up, we would be spending a lot more money treating symptoms that can be alleviated effectively by OTC medicines in our pharmacy or supermarket and, more often than not, resolve on their own.

So why do some groups want to keep Americans shackled to our current system of care? As Eric Topol notes in “The Creative Destruction of Medicine,” access to our “own data and information - whether it be DNA sequence or biosensor remote monitoring - will soon be unprecedented, and surely each individual has more at stake about his or her health than the busy physician who is looking after hundreds to thousands of patients … But change cannot take place unless consumers are the driving force.” Without the ability to conveniently access and use more medicines we know and trust in tandem with such valuable personal health information, the paternalism of the present health care system will prevail. Opponents of the FDA proposal are afraid of losing control over our lives.

There is wisdom in the crowd. The benefits of consumer empowerment outweigh the risks that, in fact, can be managed mostly by we the people by educating each other. Turning more prescription medicines into OTC products not only saves time and money. It enhances our ability to sustain health rather than just treat disease.

Illustration: Dangerous drugs by John Camejo for The Washington TimesIllustration: Dangerous drugs by John Camejo for The Washington Times

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog